DK0898708T3 - Interaktion af cyclin D1 og estrogenreceptor og anvendelse deraf i assays - Google Patents

Interaktion af cyclin D1 og estrogenreceptor og anvendelse deraf i assays

Info

Publication number
DK0898708T3
DK0898708T3 DK97920694T DK97920694T DK0898708T3 DK 0898708 T3 DK0898708 T3 DK 0898708T3 DK 97920694 T DK97920694 T DK 97920694T DK 97920694 T DK97920694 T DK 97920694T DK 0898708 T3 DK0898708 T3 DK 0898708T3
Authority
DK
Denmark
Prior art keywords
pct
cyclin
interaction
estrogen receptor
assays
Prior art date
Application number
DK97920694T
Other languages
Danish (da)
English (en)
Inventor
Rene Bernards
Rob J A M Michalides
Renate M L Zwijsen
Original Assignee
Prolifix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prolifix Ltd filed Critical Prolifix Ltd
Application granted granted Critical
Publication of DK0898708T3 publication Critical patent/DK0898708T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743Steroid hormones
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
DK97920694T 1996-04-19 1997-04-16 Interaktion af cyclin D1 og estrogenreceptor og anvendelse deraf i assays DK0898708T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9608143.5A GB9608143D0 (en) 1996-04-19 1996-04-19 Assay
PCT/EP1997/001888 WO1997040378A1 (en) 1996-04-19 1997-04-16 Interaction of cyclin d1 and estrogen receptor and its use in assays

Publications (1)

Publication Number Publication Date
DK0898708T3 true DK0898708T3 (da) 2002-03-04

Family

ID=10792355

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97920694T DK0898708T3 (da) 1996-04-19 1997-04-16 Interaktion af cyclin D1 og estrogenreceptor og anvendelse deraf i assays

Country Status (10)

Country Link
US (1) US6033843A (de)
EP (1) EP0898708B1 (de)
JP (1) JP2000508777A (de)
AT (1) ATE308497T1 (de)
AU (1) AU2698197A (de)
CA (1) CA2249396A1 (de)
DE (1) DE69708081T2 (de)
DK (1) DK0898708T3 (de)
GB (1) GB9608143D0 (de)
WO (1) WO1997040378A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999018124A1 (en) * 1997-10-07 1999-04-15 Merck & Co., Inc. Assays for nuclear receptor ligands using fret
AU2533499A (en) 1998-02-12 1999-08-30 Prolifix Limited Interaction between cyclin d1 and steroid receptor co-activators and uses thereof in assays
US6210924B1 (en) * 1998-08-11 2001-04-03 Amgen Inc. Overexpressing cyclin D 1 in a eukaryotic cell line
WO2001059448A1 (fr) * 2000-02-10 2001-08-16 Chugai Seiyaku Kabushiki Kaisha Procede de criblage d'un agent antiandrogene
ATE445164T1 (de) * 2000-06-22 2009-10-15 Univ Paris Descartes Zusammensetzungen und methoden zum nachweis, behandeln oder vorhersagen der antwort von brust tumorzellen auf eine endocrin-therapie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69325383T2 (de) * 1992-10-29 1999-11-25 Medical Research Council, London Testreihenanalyse-Verfahren mit transkriptionsfaktor DP-1

Also Published As

Publication number Publication date
EP0898708A1 (de) 1999-03-03
WO1997040378A1 (en) 1997-10-30
DE69708081T2 (de) 2002-07-04
DE69708081D1 (de) 2001-12-13
AU2698197A (en) 1997-11-12
GB9608143D0 (en) 1996-06-26
US6033843A (en) 2000-03-07
CA2249396A1 (en) 1997-10-30
EP0898708B1 (de) 2001-11-07
ATE308497T1 (de) 2001-11-15
JP2000508777A (ja) 2000-07-11

Similar Documents

Publication Publication Date Title
TR200003513T2 (tr) Pirolo[2,3d]Pirimidin kompozisyonları ve kullanımları
PT1053256E (pt) Anticorpos para o receptor de morte 4 (dr4) e utilizações destes
DE69918072D1 (de) P53-regulierte gene
BR0208456A (pt) Métodos para cultura de circovìrus
ATE309378T1 (de) Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung
BR0312764A (pt) Cardiomiócitos funcionais originados de células-tronco embrionárias humanas
BR9811956B1 (pt) naftiridinonas e composição farmacêutica compreendendo as mesmas.
IL117425A0 (en) Receptor activation by gas6
ATE435655T1 (de) Verwendung von agonistischen 4-1bb antikörpern zur erhöhung der immunantwort
YU83600A (sh) Adenozin a3 receptorski modulatori
DE60131430D1 (de) Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion
EP1616942A3 (de) Patched Gene und ihre Verwendung
DK0922102T3 (da) Receptor-agonister af hepatocyt-vækstfaktor og anvendelser deraf
DE69512219D1 (de) Gezielte spaltung von rns mittels gezielter bindung der ribonuklease p und spaltungssequenzen
TR200003377T2 (tr) Estrojenler ile bütünleşik 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol
ATE431416T1 (de) Enzymatische synthese von deoxyribonucleotiden
DK0701604T3 (da) Immortalisering af dendritiske celler med V-myc-onkogenet
NO971341L (no) Promoter for reseptor tyrosinkinase TIE
ES8402346A1 (es) Procedimiento para la obtencion de lineas de celulas animales y humanas cultivables permanentemente.
DK0898708T3 (da) Interaktion af cyclin D1 og estrogenreceptor og anvendelse deraf i assays
FR2842822B1 (fr) Procede de preparation d'une matrice extracellulaire et son utilisation pour la culture de cellules tumorales
DE69426534D1 (de) Transfizierte zelllinien die autoantigene exprimieren und ihre verwendung in immunotests zur erkennung von autoimmunkrankheiten
DE59508100D1 (de) Verwendung von zelladhäsions-peptiden zur modifikation des haftungsvermögens eukaryontischer zellen untereinander
DK1144666T3 (da) Replikationsdeficient baculovirusekspressionssystem
HUP0101393A1 (hu) Redukáló körülményekre érzékeny transzfektáló kompozíciók, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk